Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-018640
Filing Date
2013-03-27
Accepted
2013-03-27 17:40:56
Documents
1
Period of Report
2013-03-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3242
  Complete submission text file 0001209191-13-018640.txt   4569
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Issuer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address
Bernard Gordon R (Reporting) CIK: 0001470015 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33637 | Film No.: 13720937